News & insights
6 articles
Platform updates
Core instruments now number 13. The 300 kV cryo-EM will be used for epitope analysis and complex-structure confirmation, supporting antigen design and antibody screening on membrane proteins and other hard targets.
Milestones
Deliveries span mammalian, insect, yeast, E. coli and cell-free systems, with hard targets such as multi-pass membrane proteins taking a growing share.
Product updates
New SKUs concentrate on solid tumours and autoimmune disease; every in-stock item ships immediately with purity data and ELISA binding validation.
Technical articles
A review of MSLN expression, five oncogenic mechanisms and the ADC/bispecific/CAR landscape, with SanjingBio's human/cyno MSLN binding and internalisation data.
Technical articles
Two long-form articles cover VHH structural and development advantages, plus the clinical progress of approved and investigational nanobody drugs — available in Chinese and English.
Milestones
The pipeline list has been updated to 114 targets; every validated target is backed by experimental records from antigen preparation, antibody screening or functional validation.
Share the intended application and what you already have in hand. A scientist — not a sales rep — will scope feasibility, suggest the right route and send a quote, usually within one business day.
